Optimising mothers' health behaviour after hypertensive disorders of pregnancy: a qualitative study of a postnatal intervention.

Chris Rossiter, Amanda Henry, Lynne Roberts, Mark A Brown, Megan Gow, Clare Arnott, Justine Salisbury, Annette Ruhotas, Angela Hehir, Elizabeth Denney-Wilson

Journal: BMC public health 2022;22(1):1259

PMID: 35761317

Abstract

BACKGROUND

Hypertensive disorders of pregnancy have longer-term implications, increasing women's lifetime cardiovascular disease risk. The Blood Pressure Postpartum study is a multi-centre randomised three-arm trial of interventions, ranging in intensity and including education and lifestyle coaching, to support women to maintain or adopt healthy eating and physical activity during the first postpartum year. This qualitative sub-study nested within the main trial aimed to investigate whether and how women adopted healthy behaviours after a pregnancy complicated by a hypertensive disorder.

METHODS

Semi-structured telephone interviews were recorded, transcribed and analysed thematically, following Braun and Clarke principles. They explored behaviour change among new mothers following their hypertensive pregnancy, and the intervention's effect on their capacity and motivation to pursue healthy lifestyles.

RESULTS

Thirty-four women from all three trial arms participated at 10-12 months postpartum. The three main themes were 1) Awareness of cardiovascular risk: some did not acknowledge the health risks, whereas others embraced this information. 2) Sources of motivation: while the majority were motivated to make a concerted effort to adapt their health behaviour, motivation often centred on their baby and family rather than their own needs. 3) Sustaining behaviour change with a new baby: women in the more intensive intervention arm demonstrated increased recognition of the importance of reducing cardiovascular health risks, with greater motivation and guidance to change their health behaviour. There was minimal evidence of crossover amongst groups, with women largely accepting their randomised level of intervention and not seeking additional help when randomised to minimal intervention.

CONCLUSIONS

Among women participating in an early post-hypertensive disorders of pregnancy randomised controlled trial aimed at improving their cardiovascular disease risk profile, the majority recognised the future health risks and appeared motivated to improve their lifestyle, particularly women in the highest-intensity intervention group. This highlights the importance of structured support to assist women embrace healthy lifestyles especially during the challenges of new parenthood.

TRIAL REGISTRATION

The Blood Pressure Postpartum study was prospectively registered as a clinical trial with the Australian New Zealand Clinical Trials Registry (anzctr.org.au) on 13 December 2018 (registration number: ACTRN12618002004246).

© 2022. The Author(s).

Address: Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.; Discipline of Women's Health, Faculty of Medicine and Health, The University of New South Wales, Kensington, NSW, 1466, Australia. [email protected].; Department of Women's and Children's Health, St George Hospital, Kogarah, NSW, 2217, Australia. [email protected].; Department of Women's and Children's Health, St George Hospital, Kogarah, NSW, 2217, Australia.; St George and Sutherland Clinical School, The University of New South Wales, St George Hospital, Kogarah, NSW, 2217, Australia.; Department of Renal Medicine, St George Hospital and the University of NSW, Sydney, Australia.; The University of Sydney Children's Hospital Westmead Clinical School, Westmead, NSW, 2145, Australia.; The George Institute for Global Health, The University of New South Wales, 1 King Street, Newtown, NSW, 2042, Australia.; Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia.; NSW Ministry of Health, 1 Reserve Road, St Leonards, NSW, 2065, Australia.; Consumer and Community Involvement Representative, Sydney, Australia.; Sydney Local Health District, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.